HEADER MOTOR PROTEIN 22-SEP-11 4A28 TITLE EG5-2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: KINESIN-LIKE PROTEIN KIF11; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: MOTOR DOMAIN, RESIDUES 1-368; COMPND 5 SYNONYM: KINESIN-LIKE PROTEIN 1, KINESIN-LIKE SPINDLE PROTEIN HKSP, COMPND 6 KINESIN-RELATED MOTOR PROTEIN EG5, EG5-2, THYROID RECEPTOR- COMPND 7 INTERACTING PROTEIN 5, TR-INTERACTING PROTEIN 5, TRIP-5; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEX KEYWDS MOTOR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.K.TALAPATRA,F.KOZIELSKI REVDAT 4 20-DEC-23 4A28 1 REMARK LINK REVDAT 3 04-SEP-13 4A28 1 JRNL REVDAT 2 31-JUL-13 4A28 1 JRNL REVDAT 1 31-OCT-12 4A28 0 JRNL AUTH S.K.TALAPATRA,N.G.ANTHONY,S.P.MACKAY,F.KOZIELSKI JRNL TITL THE MITOTIC KINESIN EG5 OVERCOMES INHIBITION TO THE PHASE JRNL TITL 2 I/II CLINICAL CANDIDATE SB743921 BY AN ALLOSTERIC RESISTANCE JRNL TITL 3 MECHANISM. JRNL REF J.MED.CHEM. V. 56 6317 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23875972 JRNL DOI 10.1021/JM4006274 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 24503 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1239 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.5074 - 5.2952 0.98 2606 150 0.1980 0.2552 REMARK 3 2 5.2952 - 4.2069 0.99 2642 130 0.1501 0.2027 REMARK 3 3 4.2069 - 3.6762 0.99 2593 149 0.1565 0.2332 REMARK 3 4 3.6762 - 3.3406 0.99 2595 138 0.1770 0.2804 REMARK 3 5 3.3406 - 3.1015 0.99 2583 119 0.1761 0.2934 REMARK 3 6 3.1015 - 2.9188 0.99 2592 137 0.1999 0.2791 REMARK 3 7 2.9188 - 2.7727 0.99 2551 155 0.2133 0.3529 REMARK 3 8 2.7727 - 2.6521 0.99 2553 137 0.2042 0.3182 REMARK 3 9 2.6521 - 2.5501 0.98 2549 124 0.2205 0.3431 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 48.03 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.850 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.780 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 38.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.34 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.26790 REMARK 3 B22 (A**2) : -6.16440 REMARK 3 B33 (A**2) : -11.10350 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -4.68360 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 5186 REMARK 3 ANGLE : 1.472 7026 REMARK 3 CHIRALITY : 0.103 841 REMARK 3 PLANARITY : 0.007 891 REMARK 3 DIHEDRAL : 17.625 1944 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4A28 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-SEP-11. REMARK 100 THE DEPOSITION ID IS D_1290049736. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-NOV-10 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 10 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07230 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12271 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.550 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.29000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1II6 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.19500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ALA 133 TO ASP REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ALA 133 TO ASP REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 GLN A 4 REMARK 465 PRO A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 LYS A 10 REMARK 465 LYS A 11 REMARK 465 LYS A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 LYS A 15 REMARK 465 PRO A 121 REMARK 465 ASN A 122 REMARK 465 GLU A 123 REMARK 465 GLU A 124 REMARK 465 TYR A 125 REMARK 465 THR A 126 REMARK 465 TRP A 127 REMARK 465 ASN A 271 REMARK 465 ILE A 272 REMARK 465 GLY A 273 REMARK 465 ARG A 274 REMARK 465 SER A 275 REMARK 465 GLY A 276 REMARK 465 ALA A 277 REMARK 465 VAL A 278 REMARK 465 ASP A 279 REMARK 465 LYS A 280 REMARK 465 VAL A 365 REMARK 465 ASN A 366 REMARK 465 GLN A 367 REMARK 465 LYS A 368 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 GLN B 4 REMARK 465 PRO B 5 REMARK 465 ASN B 6 REMARK 465 SER B 7 REMARK 465 SER B 8 REMARK 465 ALA B 9 REMARK 465 LYS B 10 REMARK 465 LYS B 11 REMARK 465 LYS B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 14 REMARK 465 LYS B 15 REMARK 465 GLY B 55 REMARK 465 GLY B 56 REMARK 465 LEU B 57 REMARK 465 ALA B 58 REMARK 465 ASP B 59 REMARK 465 LYS B 60 REMARK 465 SER B 61 REMARK 465 ASN B 122 REMARK 465 GLU B 123 REMARK 465 GLU B 124 REMARK 465 TYR B 125 REMARK 465 THR B 126 REMARK 465 TRP B 127 REMARK 465 ARG B 274 REMARK 465 SER B 275 REMARK 465 GLY B 276 REMARK 465 ALA B 277 REMARK 465 VAL B 278 REMARK 465 ASP B 279 REMARK 465 LYS B 280 REMARK 465 ARG B 281 REMARK 465 ALA B 282 REMARK 465 ARG B 283 REMARK 465 GLU B 284 REMARK 465 ALA B 285 REMARK 465 GLY B 286 REMARK 465 ASN B 287 REMARK 465 ILE B 288 REMARK 465 ASN B 366 REMARK 465 GLN B 367 REMARK 465 LYS B 368 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 42 CG CD OE1 OE2 REMARK 470 ARG A 63 CZ NH1 NH2 REMARK 470 LYS A 64 CD CE NZ REMARK 470 GLU A 128 CG CD OE1 OE2 REMARK 470 GLU A 145 CG CD OE1 OE2 REMARK 470 GLU A 166 CG CD OE1 OE2 REMARK 470 ASP A 186 OD1 OD2 REMARK 470 ARG A 189 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 LYS A 216 CG CD CE NZ REMARK 470 ARG A 234 CD NE CZ NH1 NH2 REMARK 470 ARG A 281 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 283 CD NE CZ NH1 NH2 REMARK 470 GLN A 290 CG CD OE1 NE2 REMARK 470 HIS A 308 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 192 CD NE CZ NH1 NH2 REMARK 470 ARG B 327 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 344 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O SER B 323 O HOH B 2029 2.12 REMARK 500 N6 ADP A 1365 O HOH A 2003 2.13 REMARK 500 OH TYR A 66 OE2 GLU A 351 2.13 REMARK 500 O HOH B 2038 O HOH B 2086 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 95 2.27 -69.87 REMARK 500 ARG A 119 -61.88 -96.15 REMARK 500 VAL A 178 -164.90 -165.49 REMARK 500 ARG A 192 -14.43 66.08 REMARK 500 GLU A 253 86.61 63.47 REMARK 500 ARG A 305 -2.63 63.51 REMARK 500 PRO A 307 -175.04 -61.61 REMARK 500 HIS A 308 70.57 61.89 REMARK 500 LEU A 324 -74.84 -115.30 REMARK 500 LYS B 17 -109.91 57.31 REMARK 500 SER B 176 -141.44 56.63 REMARK 500 LYS B 207 -70.15 -48.21 REMARK 500 ASP B 251 -6.98 81.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1366 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 112 OG1 REMARK 620 2 ADP A1365 O1B 88.0 REMARK 620 3 HOH A2047 O 80.1 163.3 REMARK 620 4 HOH A2049 O 79.2 87.1 79.3 REMARK 620 5 HOH A2050 O 92.6 98.3 93.9 170.1 REMARK 620 6 HOH A2090 O 167.8 104.1 87.7 99.2 87.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B1367 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR B 112 OG1 REMARK 620 2 ADP B1366 O1B 94.0 REMARK 620 3 HOH B2037 O 81.0 70.3 REMARK 620 4 HOH B2038 O 105.2 109.4 173.7 REMARK 620 5 HOH B2039 O 89.8 152.5 83.4 95.7 REMARK 620 6 HOH B2106 O 169.8 78.5 89.9 84.0 93.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 1365 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1366 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 1366 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 1367 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FKY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 13 REMARK 900 RELATED ID: 2X7C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN KINESIN EG5 IN COMPLEX WITH (S)-ENASTRON REMARK 900 RELATED ID: 2XAE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN KINESIN EG5 IN COMPLEX WITH (R)-2-AMINO- REMARK 900 3-((S)-2-METHYL-1,1-DIPHENYLBUTYLTHIO )PROPANOIC ACID REMARK 900 RELATED ID: 1Q0B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MOTOR PROTEIN KSP IN COMPLEX WITHADP AND REMARK 900 MONASTROL REMARK 900 RELATED ID: 2X2R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN KINESIN EG5 IN COMPLEX WITH (R)-2-AMINO- REMARK 900 3-((4-CHLOROPHENYL)DIPHENYLMETHYLTHIO) PROPANOIC ACID REMARK 900 RELATED ID: 2FL6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 6 REMARK 900 RELATED ID: 2UYM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH ADP AND THIOPHENE REMARK 900 CONTAINING INHIBITOR 37 REMARK 900 RELATED ID: 2X7D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN KINESIN EG5 IN COMPLEX WITH (S)- REMARK 900 DIMETHYLENASTRON REMARK 900 RELATED ID: 2X7E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN KINESIN EG5 IN COMPLEX WITH (R)- REMARK 900 FLUORASTROL REMARK 900 RELATED ID: 1II6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MITOTIC KINESIN EG5 IN COMPLEXWITH MG-ADP. REMARK 900 RELATED ID: 2UYI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH ADP AND THIOPHENE REMARK 900 CONTAINING INHIBITOR 33 REMARK 900 RELATED ID: 2WOG RELATED DB: PDB REMARK 900 INTERMEDIATE AND FINAL STATES OF HUMAN KINESIN EG5 IN COMPLEX WITH REMARK 900 S-TRITYL-L-CYSTEINE REMARK 900 RELATED ID: 4A1Z RELATED DB: PDB REMARK 900 EG5-1 REMARK 900 RELATED ID: 2G1Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 9H REMARK 900 RELATED ID: 1YRS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 1 REMARK 900 RELATED ID: 2GM1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MITOTIC KINESIN EG5 IN COMPLEXWITH MG-ADP REMARK 900 AND N-(3-AMINOPROPYL)-N-((3- BENZYL-5-CHLORO-4-OXO-3,4- REMARK 900 DIHYDROPYRROLO[2,1-F][ 1,2,4]TRIAZIN-2-YL)(CYCLOPROPYL)METHYL)-4- REMARK 900 METHYLBENZAMIDE REMARK 900 RELATED ID: 1X88 RELATED DB: PDB REMARK 900 HUMAN EG5 MOTOR DOMAIN BOUND TO MG-ADP AND MONASTROL REMARK 900 RELATED ID: 2FL2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH INHIBITOR 19 REMARK 999 REMARK 999 SEQUENCE REMARK 999 LOOP L5 MISSING. DBREF 4A28 A 1 368 UNP P52732 KIF11_HUMAN 1 368 DBREF 4A28 B 1 368 UNP P52732 KIF11_HUMAN 1 368 SEQADV 4A28 ASP A 133 UNP P52732 ALA 133 ENGINEERED MUTATION SEQADV 4A28 ASP B 133 UNP P52732 ALA 133 ENGINEERED MUTATION SEQRES 1 A 368 MET ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU SEQRES 2 A 368 GLU LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG SEQRES 3 A 368 PRO PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER SEQRES 4 A 368 ILE VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL SEQRES 5 A 368 ARG THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR SEQRES 6 A 368 TYR THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN SEQRES 7 A 368 ILE ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP SEQRES 8 A 368 GLU VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR SEQRES 9 A 368 GLY GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY SEQRES 10 A 368 GLU ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP SEQRES 11 A 368 PRO LEU ASP GLY ILE ILE PRO ARG THR LEU HIS GLN ILE SEQRES 12 A 368 PHE GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL SEQRES 13 A 368 LYS VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE SEQRES 14 A 368 ASP LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU SEQRES 15 A 368 GLN MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE SEQRES 16 A 368 ILE LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP SEQRES 17 A 368 GLU VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG SEQRES 18 A 368 THR THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SEQRES 19 A 368 SER HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU SEQRES 20 A 368 THR THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS SEQRES 21 A 368 LEU ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY SEQRES 22 A 368 ARG SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY SEQRES 23 A 368 ASN ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE SEQRES 24 A 368 THR ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG SEQRES 25 A 368 GLU SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY SEQRES 26 A 368 GLY ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO SEQRES 27 A 368 ALA SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU SEQRES 28 A 368 TYR ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU SEQRES 29 A 368 VAL ASN GLN LYS SEQRES 1 B 368 MET ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU SEQRES 2 B 368 GLU LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG SEQRES 3 B 368 PRO PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER SEQRES 4 B 368 ILE VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL SEQRES 5 B 368 ARG THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR SEQRES 6 B 368 TYR THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN SEQRES 7 B 368 ILE ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP SEQRES 8 B 368 GLU VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR SEQRES 9 B 368 GLY GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY SEQRES 10 B 368 GLU ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP SEQRES 11 B 368 PRO LEU ASP GLY ILE ILE PRO ARG THR LEU HIS GLN ILE SEQRES 12 B 368 PHE GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL SEQRES 13 B 368 LYS VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE SEQRES 14 B 368 ASP LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU SEQRES 15 B 368 GLN MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE SEQRES 16 B 368 ILE LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP SEQRES 17 B 368 GLU VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG SEQRES 18 B 368 THR THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SEQRES 19 B 368 SER HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU SEQRES 20 B 368 THR THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS SEQRES 21 B 368 LEU ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY SEQRES 22 B 368 ARG SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY SEQRES 23 B 368 ASN ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE SEQRES 24 B 368 THR ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG SEQRES 25 B 368 GLU SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY SEQRES 26 B 368 GLY ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO SEQRES 27 B 368 ALA SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU SEQRES 28 B 368 TYR ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU SEQRES 29 B 368 VAL ASN GLN LYS HET ADP A1365 27 HET MG A1366 1 HET ADP B1366 27 HET MG B1367 1 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM MG MAGNESIUM ION FORMUL 3 ADP 2(C10 H15 N5 O10 P2) FORMUL 4 MG 2(MG 2+) FORMUL 7 HOH *199(H2 O) HELIX 1 1 ASN A 29 ALA A 35 1 7 HELIX 2 2 LYS A 77 VAL A 86 1 10 HELIX 3 3 VAL A 86 MET A 95 1 10 HELIX 4 4 GLY A 110 GLU A 116 1 7 HELIX 5 5 GLY A 134 ASN A 150 1 17 HELIX 6 6 ASN A 206 ASP A 208 5 3 HELIX 7 7 GLU A 209 LEU A 227 1 19 HELIX 8 8 TYR A 231 SER A 235 5 5 HELIX 9 9 ARG A 281 ARG A 305 1 25 HELIX 10 10 PRO A 310 GLU A 313 5 4 HELIX 11 11 SER A 314 LEU A 320 1 7 HELIX 12 12 GLN A 321 LEU A 324 5 4 HELIX 13 13 ASN A 342 LYS A 357 1 16 HELIX 14 14 ASN B 29 ALA B 35 1 7 HELIX 15 15 LYS B 77 MET B 95 1 19 HELIX 16 16 GLY B 110 GLU B 116 1 7 HELIX 17 17 GLY B 134 ASN B 150 1 17 HELIX 18 18 ASP B 208 ASN B 229 1 22 HELIX 19 19 TYR B 231 SER B 235 5 5 HELIX 20 20 GLY B 268 ILE B 272 5 5 HELIX 21 21 ASN B 289 ARG B 305 1 17 HELIX 22 22 PRO B 310 GLU B 313 5 4 HELIX 23 23 SER B 314 GLN B 321 1 8 HELIX 24 24 ASN B 342 LYS B 357 1 16 SHEET 1 AA 8 MET A 70 PHE A 72 0 SHEET 2 AA 8 ILE A 19 CYS A 25 1 O VAL A 23 N PHE A 72 SHEET 3 AA 8 THR A 330 ILE A 336 1 O THR A 330 N GLN A 20 SHEET 4 AA 8 ASN A 98 GLY A 105 1 O THR A 100 N SER A 331 SHEET 5 AA 8 LEU A 255 ASP A 265 1 O LYS A 260 N CYS A 99 SHEET 6 AA 8 HIS A 236 GLU A 247 -1 O SER A 237 N ASP A 265 SHEET 7 AA 8 GLU A 153 ILE A 163 -1 O GLU A 153 N LYS A 246 SHEET 8 AA 8 LEU A 168 ASP A 170 -1 O PHE A 169 N GLU A 162 SHEET 1 AB 8 MET A 70 PHE A 72 0 SHEET 2 AB 8 ILE A 19 CYS A 25 1 O VAL A 23 N PHE A 72 SHEET 3 AB 8 THR A 330 ILE A 336 1 O THR A 330 N GLN A 20 SHEET 4 AB 8 ASN A 98 GLY A 105 1 O THR A 100 N SER A 331 SHEET 5 AB 8 LEU A 255 ASP A 265 1 O LYS A 260 N CYS A 99 SHEET 6 AB 8 HIS A 236 GLU A 247 -1 O SER A 237 N ASP A 265 SHEET 7 AB 8 GLU A 153 ILE A 163 -1 O GLU A 153 N LYS A 246 SHEET 8 AB 8 ILE A 202 VAL A 204 -1 O ILE A 202 N VAL A 158 SHEET 1 AC 2 LEU A 168 ASP A 170 0 SHEET 2 AC 2 GLU A 153 ILE A 163 -1 O GLU A 162 N PHE A 169 SHEET 1 AD 3 VAL A 41 ASP A 44 0 SHEET 2 AD 3 GLU A 49 ARG A 53 -1 O GLU A 49 N ASP A 44 SHEET 3 AD 3 ARG A 63 THR A 67 -1 O LYS A 64 N VAL A 52 SHEET 1 AE 2 MET A 184 PHE A 185 0 SHEET 2 AE 2 ILE A 195 ILE A 196 -1 O ILE A 195 N PHE A 185 SHEET 1 BA 8 MET B 70 PHE B 72 0 SHEET 2 BA 8 ILE B 19 CYS B 25 1 O VAL B 23 N PHE B 72 SHEET 3 BA 8 THR B 330 ILE B 336 1 O THR B 330 N GLN B 20 SHEET 4 BA 8 ASN B 98 GLY B 105 1 O THR B 100 N SER B 331 SHEET 5 BA 8 GLU B 254 ASP B 265 1 O LYS B 260 N CYS B 99 SHEET 6 BA 8 HIS B 236 THR B 248 -1 O SER B 237 N ASP B 265 SHEET 7 BA 8 GLU B 153 TYR B 164 -1 O GLU B 153 N LYS B 246 SHEET 8 BA 8 GLU B 167 ASP B 170 -1 O GLU B 167 N TYR B 164 SHEET 1 BB 8 MET B 70 PHE B 72 0 SHEET 2 BB 8 ILE B 19 CYS B 25 1 O VAL B 23 N PHE B 72 SHEET 3 BB 8 THR B 330 ILE B 336 1 O THR B 330 N GLN B 20 SHEET 4 BB 8 ASN B 98 GLY B 105 1 O THR B 100 N SER B 331 SHEET 5 BB 8 GLU B 254 ASP B 265 1 O LYS B 260 N CYS B 99 SHEET 6 BB 8 HIS B 236 THR B 248 -1 O SER B 237 N ASP B 265 SHEET 7 BB 8 GLU B 153 TYR B 164 -1 O GLU B 153 N LYS B 246 SHEET 8 BB 8 ILE B 202 VAL B 204 -1 O ILE B 202 N VAL B 158 SHEET 1 BC 2 GLU B 167 ASP B 170 0 SHEET 2 BC 2 GLU B 153 TYR B 164 -1 O GLU B 162 N PHE B 169 SHEET 1 BD 3 VAL B 41 ASP B 44 0 SHEET 2 BD 3 GLU B 49 ARG B 53 -1 O GLU B 49 N ASP B 44 SHEET 3 BD 3 ARG B 63 THR B 67 -1 O LYS B 64 N VAL B 52 SHEET 1 BE 2 GLN B 183 ASP B 187 0 SHEET 2 BE 2 ASN B 190 LYS B 197 -1 O ASN B 190 N ASP B 187 LINK OG1 THR A 112 MG MG A1366 1555 1555 2.27 LINK O1B ADP A1365 MG MG A1366 1555 1555 2.41 LINK MG MG A1366 O HOH A2047 1555 1555 2.38 LINK MG MG A1366 O HOH A2049 1555 1555 2.26 LINK MG MG A1366 O HOH A2050 1555 1555 2.31 LINK MG MG A1366 O HOH A2090 1555 1555 2.34 LINK OG1 THR B 112 MG MG B1367 1555 1555 2.23 LINK O1B ADP B1366 MG MG B1367 1555 1555 2.20 LINK MG MG B1367 O HOH B2037 1555 1555 2.46 LINK MG MG B1367 O HOH B2038 1555 1555 2.28 LINK MG MG B1367 O HOH B2039 1555 1555 2.28 LINK MG MG B1367 O HOH B2106 1555 1555 2.25 SITE 1 AC1 17 ARG A 24 ARG A 26 GLN A 106 GLY A 108 SITE 2 AC1 17 THR A 109 GLY A 110 LYS A 111 THR A 112 SITE 3 AC1 17 PHE A 113 GLU A 118 MG A1366 HOH A2003 SITE 4 AC1 17 HOH A2004 HOH A2049 HOH A2089 HOH A2090 SITE 5 AC1 17 LYS B 34 SITE 1 AC2 6 THR A 112 ADP A1365 HOH A2047 HOH A2049 SITE 2 AC2 6 HOH A2050 HOH A2090 SITE 1 AC3 20 LYS A 34 HOH A2009 ARG B 24 ARG B 26 SITE 2 AC3 20 PRO B 27 GLN B 106 THR B 107 GLY B 108 SITE 3 AC3 20 THR B 109 GLY B 110 LYS B 111 THR B 112 SITE 4 AC3 20 PHE B 113 GLU B 118 MG B1367 HOH B2021 SITE 5 AC3 20 HOH B2036 HOH B2037 HOH B2106 HOH B2108 SITE 1 AC4 6 THR B 112 ADP B1366 HOH B2037 HOH B2038 SITE 2 AC4 6 HOH B2039 HOH B2106 CRYST1 52.900 78.390 92.690 90.00 93.16 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018904 0.000000 0.001044 0.00000 SCALE2 0.000000 0.012757 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010805 0.00000